Bone marrow-derived allogeneic stem cell therapy shortly after ischemic stroke did not improve outcomes at 90 days, a phase II/III randomized clinical trial known as TREASURE found. However, ...
PUERTO VALLARTA, Mexico — In the world of regenerative medicine, a new type of stem cell is generating excitement among scientists, physicians, and patients alike: MUSE cells, short for Multilineage ...
New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy
Chimeric antigen receptor T cells—CAR T cells for short—are immune cells (T cells) that are taken from the body and genetically modified outside the body in the laboratory using transport vehicles for ...
Alzheimer's disease, which is expected to have affected about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells. But the events that cause neuron death are poorly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results